BioAmber Inc. announced that as a result of the liquidation process, all of the directors and officers of the company and its subsidiaries have resigned, leaving PWC to oversee the process in its role as monitor, under the supervision of the court. On August 28, 2018, Kurt Briner, Robert Frost, Heinz Haller, Ellen Richstone and Kenneth Wall each resigned from the Board of Directors of the company, including all committees thereof, and on August 29, 2018, Raymond Land resigned from the Board and all committees thereof. On August 31, 2018, Richard Eno, the company's chief executive officer and director, Michael Hartmann, the company's executive vice-president, James Millis, the company's chief technology officer and Mario Settino, the company's chief financial officer, each voluntarily resigned from their offices at the company.